von Recklinghausen's disease associated with somatostatin-rich duodenal carcinoid (somatostatinoma), medullary thyroid carcinoma and diffuse adrenal medullary hyperplasia.
This report describes the concomitant occurrence of a somatostatin-rich duodenal carcinoid, a medullary thyroid carcinoma and a diffuse adrenal medullary hyperplasia in a patient with von Recklinghausen's disease. A 50-year-old Japanese man died from lung metastasis of a malignant schwannoma. In addition to extensive viscero-cutaneous neurofibromatosis, two different types of neuroendocrine tumors were found in the duodenum and thyroid gland at autopsy. The duodenal tumor, which was located in the second portion, showed the histologic appearance of a carcinoid tumor with glandular differentiation and psammoma-bodies. Immunohistochemically the tumor cells were intensely positive for somatostatin. The thyroid tumor was composed of nests of tumor cells arranged in an endocrine pattern, and showed immunoreactivity for calcitonin. A review of the literature revealed no previously reported case of concomitant occurrence of duodenal somatostatinoma and medullary thyroid carcinoma in a single patient with von Recklinghausen's disease. Morphometric analysis of adrenal glands disclosed the presence of diffuse medullary hyperplasia. Thus, the present case exhibited a similarity in some respects with multiple endocrine neoplasia (MEN) syndrome, Type IIa or IIb.
First Department of Pathology, Kagoshima University Faculty of Medicine, Japan.
A
A
Yoshida
S
S
Hatanaka
Y
Y
Ohi
Y
Y
Umekita
H
H
Yoshida
D000307:Adrenal Gland Diseases / Q000150:complications* / Q000473:pathology; D000313:Adrenal Medulla / Q000473:pathology*; D001344:Autopsy; D002277:Carcinoma / Q000150:complications* / Q000473:pathology; D004379:Duodenal Neoplasms / Q000737:chemistry / Q000150:complications* / Q000473:pathology; D006801:Humans; D006965:Hyperplasia / Q000473:pathology; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D009456:Neurofibromatosis 1 / Q000150:complications* / Q000473:pathology; D013004:Somatostatin / Q000032:analysis; D013005:Somatostatinoma / Q000737:chemistry / Q000150:complications* / Q000473:pathology; D013964:Thyroid Neoplasms / Q000150:complications* / Q000473:pathology
D013004:Somatostatin